Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris
Status:
Completed
Trial end date:
2013-01-31
Target enrollment:
Participant gender:
Summary
To evaluate the safety and effectiveness of 3 strengths of P005672-HCl compared to placebo
for the treatment of moderate to severe facial acne vulgaris.